Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07259707
Recruiting
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
Phase 2 · China · 1 site
Registry update: 4 Feb 2026
NCT07361783
Recruiting
Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial
Not applicable · China · 1 site
Registry update: 17 Jun 2026
NCT07206355
Recruiting
In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
Not applicable · United Kingdom · 1 site
Registry update: 29 Apr 2026
NCT07367581
Recruiting
Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Not applicable · Egypt · 1 site
Registry update: 27 Jan 2026
NCT07494305
Recruiting
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Phase 2 · United States · 26 sites
Registry update: 27 Jul 2026
NCT07223307
Recruiting
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Phase 2 · United States · 1 site
Registry update: 27 Oct 2026
NCT07184619
Recruiting
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Phase 3 · Argentina, India, Malaysia, United States · 19 sites
Registry update: 10 Sept 2026
2025-523612-37-00
Recruiting
A Study in Adults with Parkinson's Disease and a Lack of Interest or Motivation to Test How Different Doses of IRL757 Given for Multiple Days are Tolerated in the Body
Phase 1 · Bulgaria, Germany, Spain, Poland · 18 sites
Registry update: 16 Jul 2026
NCT07022405
Recruiting
Stratified Pharmacological Approaches for Regulating Circuit-Level Effects
Phase 2 · United States · 1 site
Registry update: 15 May 2026
NCT07372287
Recruiting
A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma
Phase 3 · China · 1 site
Registry update: 28 Apr 2026
NCT07221942
Recruiting
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
Phase 2 · United States · 1 site
Registry update: 19 Feb 2026
NCT07309276
Recruiting
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Phase 2 · China · 1 site
Registry update: 18 May 2026
NCT07201519
Recruiting
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Phase 2 · United States · 1 site
Registry update: 4 Feb 2026
NCT07206602
Recruiting
AI-Guided Left Bundle Branch Area Pacing
Not applicable · United States · 1 site
Registry update: 18 Feb 2026
NCT07230288
Recruiting
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Phase 2 · Australia, Bulgaria, Canada, Germany, Spain, France, United Kingdom, Greece, Hungary, Italy, Japan, South Korea, Poland, Portugal, Romania, Serbia, Sweden, Taiwan, United States, South Africa · 92 sites
Registry update: 3 Sept 2026
NCT06997094
Recruiting
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
Phase 1 · United States · 1 site
Registry update: 15 Jul 2026
NCT07277231
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Phase 3 · Australia, Brazil, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Italy, South Korea, Netherlands, New Zealand, Poland, Romania, Sweden, United States · 117 sites
Registry update: 28 Sept 2026
NCT07422857
Recruiting
Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function
Phase 3 · China · 2 sites
Registry update: 20 Feb 2026
NCT07184944
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Chile, China, Czechia, Germany, Georgia, Israel, Italy, Japan, South Korea, Lithuania, Moldova, Netherlands, New Zealand, Poland, Serbia, Slovakia, Taiwan, Ukraine, United States, South Africa · 109 sites
Registry update: 21 Oct 2026
NCT07292441
Recruiting
Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
Phase 3 · China · 1 site
Registry update: 11 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.